The World Health Organization has approved another COVID-19 vaccine for emergency use listing. Corbevax was developed by scientists at the Texas Children’s Hospital and the Baylor College of Medicine. In a press release, Texas Children’s Hospital said that 100 million doses of Corbevax have been administered in India.

Editor’s Note: Many questions arise from this article. First of all, how is the WHO able to add Corbevax to the “emergency listing” when there is no emergency? [See Is the COVID pandemic over? and this New York Times article announcing the end of the COVID ‘pandemic’].

How was the WHO able to add a new COVID shot as an “emergency” drug if the immune system is proven to be more effective than any vaccine? [See Study: Natural Immunity More Effective Protection Than Vaccine].

Why does the WHO need to add a new COVID shot to the emergency listing when no one wants the boosters? [Read this article published by the National Library of Medicine. Also, read this CNN article showing that fewer young people are taking the COVID booster shots.]

Read Original Article